{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:56:25Z","timestamp":1785491785949,"version":"3.56.0"},"reference-count":59,"publisher":"Consilium Medicum","issue":"8","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. Study of the current state of problems of treatment of patients with tuberculosis based on literature data and their own experience.\r\nMaterials and methods. In the Russian Federation, the number and proportion of patients with co-infection with HIV\/tuberculosis continues to increase against the background of improvement in the main epidemiological indicants for tuberculosis. In 2017, 20.9% of newly diagnosed tuberculosis patients had HIV infection. The combination of the two infections significantly complicates the further improvement of the situation with tuberculosis, and the appearance of drug-resistant strains of Mycobacterium tuberculosis sometimes completely neutralizes the results of chemotherapy. The article describes the schemes of modern tuberculosis chemotherapy taking into account HIV\/tuberculosis co-infection, as well as MDR in combination with surgical treatment methods, as well as analyzes the data of epidemiological monitoring of treatment of 1115 tuberculosis patients newly diagnosed in 2017 in Moscow, 360 tuberculosis patients with MDR MBT (cohort 20132014), the results of treatment with the use of new chemotherapy regimens for tuberculosis (bedaquiline, linezolid, moxifloxacin) in 36 patients, the effectiveness and safety of surgical methods in 192 patients.\r\nResults. The application of new individualized anti-TB chemotherapy schedules in patients with HIV co-infection\/tuberculosis with MDR-MBT has allowed to improve the treatment efficacy. The surgical intervention combined with modern chemotherapy regimens in patients with HIV\/tuberculosis co-infection with MDR MBT has been proved to be effective and safe, contributes to the improving the results of treatment for this category of patients.\r\nConclusion. The confluence of two global problems of co-infection HIV\/TB and MDR TB, significantly prevents from the end of the tuberculosis epidemic in the world. At the same time, advances in the development and implementation of new anti-TB drugs and surgical treatment methods give hope for significant progress for resolving this situation.<\/jats:p>","DOI":"10.26442\/00403660.2020.08.000762","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T05:42:50Z","timestamp":1599889370000},"page":"86-94","source":"Crossref","is-referenced-by-count":13,"title":["The treatment of tuberculosis under current conditions"],"prefix":"10.26442","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8951-5219","authenticated-orcid":false,"given":"M. V.","family":"Sinitsyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5327-496X","authenticated-orcid":false,"given":"M. V.","family":"Kalinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3456-3069","authenticated-orcid":false,"given":"E. M.","family":"Belilovskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9893-0841","authenticated-orcid":false,"given":"A. S.","family":"Galstyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4418-4601","authenticated-orcid":false,"given":"M. N.","family":"Reshetnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6659-7888","authenticated-orcid":false,"given":"D. V.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Global Tuberculosis Report 2019. Geneva, 2019. https:\/\/www.who.int\/tb\/publications\/global_report\/en\/"},{"key":"ref2","unstructured":"\u0421\u043e\u0446\u0438\u0430\u043b\u044c\u043d\u043e \u0437\u043d\u0430\u0447\u0438\u043c\u044b\u0435 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f \u0420\u043e\u0441\u0441\u0438\u0438 \u0432 2018 \u0433\u043e\u0434\u0443. \u0421\u0442\u0430\u0442\u0438\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043c\u0430\u0442\u0435\u0440\u0438\u0430\u043b\u044b. \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432 \u0420\u0424, 2019 [Sotsial\u2019no znachimye zabolevaniya naseleniya Rossii v 2018 godu (Statisticheskie materialy). Minzdrav RF, 2019 (In Russ.)]. https:\/\/www.rosminzdrav.ru\/ministry\/61\/22\/stranitsa-979\/statisticheskie-i-informatsionnye-materialy\/statisticheskiy-sbornik-2018-god"},{"key":"ref3","unstructured":"\u042d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0441\u0438\u0442\u0443\u0430\u0446\u0438\u044f \u043f\u043e \u0442\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437\u0443 \u0432 \u0420\u043e\u0441\u0441\u0438\u0438, 2018. \u0426\u041d\u0418\u0418\u041e\u0418\u0417 \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u0424, 2019 [Epidemiologicheskaia situatsiia po tuberkulezu v Rossii, 2018. TsNIIOIZ Minzdrava RF, 2019 (In Russ.)]. https:\/\/mednet.ru\/images\/materials\/CMT\/2018_god_tuberkulez_ epidsituaciya.pdf"},{"key":"ref4","unstructured":"\u041f\u0440\u043e\u0442\u0438\u0432\u043e\u0442\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437\u043d\u0430\u044f \u0440\u0430\u0431\u043e\u0442\u0430 \u0432 \u0433\u043e\u0440\u043e\u0434\u0435 \u041c\u043e\u0441\u043a\u0432\u0435. \u0410\u043d\u0430\u043b\u0438\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043e\u0431\u0437\u043e\u0440 \u0441\u0442\u0430\u0442\u0438\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u0435\u0439 \u043f\u043e \u0442\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437\u0443, 2018. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0415.\u041c. \u0411\u043e\u0433\u043e\u0440\u043e\u0434\u0441\u043a\u043e\u0439, \u0412.\u0418. \u041b\u0438\u0442\u0432\u0438\u043d\u043e\u0432\u0430, \u0415.\u041c. \u0411\u0435\u043b\u0438\u043b\u043e\u0432\u0441\u043a\u043e\u0433\u043e. \u041c.: \u041c\u041d\u041f\u0426\u0411\u0422, 2019 [Protivotuberkuleznaya rabota v gorode Moskve. Analiticheskii obzor statisticheskikh pokazatelei po tuberkulezu, 2018. Pod red. EM Bogorodskoi, VI Litvinova, EM Belilovskogo. Moscow: MNPTsBT, 2019 (In Russ.)]."},{"key":"ref5","unstructured":"\u0422\u0411\/\u0412\u0418\u0427 \u0432 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u0438. \u042d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u044f, \u043e\u0441\u043e\u0431\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043f\u0440\u043e\u044f\u0432\u043b\u0435\u043d\u0438\u0439 \u0438 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b \u043b\u0435\u0447\u0435\u043d\u0438\u044f. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0421.\u0410. \u0421\u0442\u0435\u0440\u043b\u0438\u043a\u043e\u0432\u0430. \u041c.: \u0420\u0418\u041e \u0426\u041d\u0418\u0418\u041e\u0418\u0417, 2017 [TB\/VICh v Rossiiskoi Federatsii. Epidemiologiya, osobennosti klinicheskikh proyavlenii i rezul\u2019taty lecheniya. Pod red. SA Sterlikova. Moscow: RIO TsNIIOIZ, 2017 (In Russ.)]."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21292\/2075-1230-2017-95-11-19-25"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/thx.38.5.326"},{"key":"ref8","unstructured":"Jacobaeus HV. Ur die Moglichkeitdie Zystoskopie bei Untersuchung seroser Hohlungen anzuwenden. Munchener Medizinische Wochenschrift. 1910;57;2090-2."},{"key":"ref9","unstructured":"Ghai SN. Extra pleural pneumonolysis with or without plombage in thoracoplasty failures: review of 21 cases. Indian J Tuberc. 1958;5(3):122-9."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1590\/1806-3713\/e20180324"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"McDermott W, Muschenheim C, Hadley SD. Streptomycin in the treatment of tuberculosis in humans. J Clin Invest. 1947;26(6):1190.","DOI":"10.7326\/0003-4819-27-6-989"},{"key":"ref12","unstructured":"\u0420\u0430\u0431\u0443\u0445\u0438\u043d \u0410.\u0415. \u0422\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437 \u043e\u0440\u0433\u0430\u043d\u043e\u0432 \u0434\u044b\u0445\u0430\u043d\u0438\u044f \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445. \u041c.: \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0430, 1976 [Rabukhin AE. Respiratory tuberculosis in adults. Moscow: Meditsina, 1976 (In Russ.)]."},{"key":"ref13","unstructured":"\u0425\u043e\u043c\u0435\u043d\u043a\u043e \u0410.\u0413. \u0425\u0438\u043c\u0438\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f \u0442\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437\u0430 \u043b\u0435\u0433\u043a\u0438\u0445. \u041c.: \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0430, 1980 [Khomenko AG. Chemotherapy for pulmonary tuberculosis. Moscow: Meditsina, 1980 (In Russ.)]."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/143.4_Pt_1.697"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.supplement_3.s402"},{"key":"ref16","unstructured":"Styblo K. Recent advances in epidemiological research in tuberculosis. Advances in Tuberculosis Research. 1980;20:1-63."},{"key":"ref17","unstructured":"Centers for Disease Control and Prevention (CDC). Pneumocystis pneumonia-Los Angeles. 1981. MMWR Morb Mortal Wkly Rep. 1996;45(34):729-33."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112103052401"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000171.pub2"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.9.1009"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-012-0311-3"},{"key":"ref23","unstructured":"National Institute for Health and Clinical Excellence. Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, 2016. https:\/\/www.nice.org.uk\/guidance\/ng33"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032482"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0053"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.20953\/1729-9225-2018-1-28-34"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00111304"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.21292\/2075-1230-2019-97-11-46-58"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1086\/597351"},{"key":"ref30","unstructured":"WHO guidelines on tuberculosis infection prevention and control, 2019 update. World Health Organization, Geneva 2019. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/311259\/9789241550512-eng.pdf?ua=1"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2019.11.000374"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.21292\/2075-1230-2017-95-10-47-52"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.21292\/2075-1230-2019-97-2-5-11"},{"key":"ref34","unstructured":"\u041b\u0438\u0442\u0432\u0438\u043d\u043e\u0432 \u0412.\u0418., \u041c\u0430\u043a\u0430\u0440\u043e\u0432\u0430 \u041c.\u0412., \u041a\u0440\u0430\u0441\u043d\u043e\u0432\u0430 \u041c.\u0410. \u041d\u0435\u0442\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437\u043d\u044b\u0435 \u043c\u0438\u043a\u043e\u0431\u0430\u043a\u0442\u0435\u0440\u0438\u0438. \u041c.: \u041c\u041d\u041f\u0426\u0411\u0422, 2008 [Litvinov VI, Makarova MV, Krasnova MA. Non-tuberculous mycobacteria. Moscow: MNPTsBT, 2008 (In Russ.)]."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.167.4.603"},{"key":"ref36","unstructured":"Centers for Disease Control and Prevention (CDC). Multidrug-resistant tuberculosis outbreak on an HIV ward-Madrid, Spain, 1991-1995. MMWR Morb Mortal Wkly Rep. 1996;45(16):330-3."},{"key":"ref37","unstructured":"\u0422\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437 \u0441 \u043c\u043d\u043e\u0436\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0439 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0439 \u0443\u0441\u0442\u043e\u0439\u0447\u0438\u0432\u043e\u0441\u0442\u044c\u044e. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0418. \u0411\u0430\u0441\u0442\u0438\u0430\u043d, \u0424. \u041f\u043e\u0440\u0442\u0430\u043b\u0441. \u041c.: \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0430 \u0438 \u0436\u0438\u0437\u043d\u044c, 2003 [Multidrug-resistant tuberculosis. Pod red. I Bastian, F Portals. Moscow: Meditsina i zhizn\u2019, 2003 (In Russ.)]."},{"key":"ref38","unstructured":"A guide to monitoring and evaluation for collaborative TB\/HIV activities, 2015 revision. World Health Organization, Geneva 2015. http:\/\/www.who.int\/tb\/publications\/monitoring-evaluation-collaborative-tb-hiv\/en\/"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa470"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00203811"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix208"},{"key":"ref42","unstructured":"\u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u0422\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437 \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445. \u041e\u0431\u0449\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043e\u0431\u0449\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u0430\u044f \u043e\u0440\u0433\u0430\u043d\u0438\u0437\u0430\u0446\u0438\u044f \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0435 \u043e\u0431\u0449\u0435\u0441\u0442\u0432\u043e \u0444\u0442\u0438\u0437\u0438\u0430\u0442\u0440\u043e\u0432\u00bb. \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432 \u0420\u0424, 2020 [Klinicheskie rekomendatsii. Tuberkulez u vzroslykh. Obshcherossiiskaya obshchestvennaya organizatsiya \u201cRossiiskoe obshchestvo ftiziatrov\u201d. Minzdrav RF, 2020 (In Russ.)]. http:\/\/cr.rosminzdrav.ru\/#!\/recomend\/943"},{"key":"ref43","unstructured":"WHO consolidated guidelines on drug-resistant tuberculosis treatment. World Health Organization, Geneva 2019. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/311389\/9789241550529-eng.pdf"},{"key":"ref44","unstructured":"Rapid communication: key changes to treatment of drug-resistant tuberculosis. World Health Organization, Geneva 2019. https:\/\/www.who.int\/tb\/publications\/2019\/WHO_RapidCommunicationMDR_TB2019.pdf?ua=1"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.042"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2979"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00387-2017"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2013.11.11"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01891-2015"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.06.011"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.21292\/2075-1230-2017-95-9-19-24"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.03.036"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0198"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneumo.2014.03.005"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3201\/eid1305.070200"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_177_16"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.01.039"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0622"},{"key":"ref59","unstructured":"Migliori GB, D\u2019Ambrosio L, Centis R, et al. Guiding principles to reduce tuberculosis transmission in the WHO European region. World Health Organization Regional Office for Europe, Copenhagen 2018. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0008\/377954\/ic-principles-eng.pdf"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/43546\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/43546\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T20:36:11Z","timestamp":1634157371000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/43546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,9,3]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2020.08.000762","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}